Angelo Keely
KION
Angelo Keely is associated with KION. He discusses health, nutrition, and fitness topics, including midlife body composition changes, muscle loss and building, dietary protein, essential amino acids, and metabolism.
20 claims checked on air: 4 contradicted 5 overstated 9 supported 2 unverified
What they said on air - supported
American society as a whole is much more overweight than it was 50 years ago.
"So even people, you know, if you look at all of society, I think in general, basically all of American society is much more overweight than it was 50 years ago." (said at 0:25:56)
Nationally representative surveillance data from the National Health Examination Survey (NHES) and the National Health and Nutrition Examination Survey (NHANES) demonstrate a substantial, multi-decade increase in body mass index (BMI), obesity, and severe obesity in the United States over the past 50 to 60 years. In the 1960s and early 1970s, adult obesity prevalence was approximately 13% to 15%, whereas recent NHANES surveys (2017–2023) show adult obesity prevalence exceeding 40% and overall overweight/obesity prevalence surpassing 70%.
- supports: Emergence of the obesity epidemic: 6-decade visualization with humanoid avatars. (The American journal of clinical nutrition 2022) · cited 21x in the literature
"There was a curvilinear increase in adult US population body mass, waist circumference, and BMI in males and females across the 9 surveys spanning 6 decades." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023. (NCHS data brief 2024) · cited 394x in the literature
"During August 2021-August 2023, the prevalence of obesity in adults was 40.3%, with no significant differences between men and women." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Increasing prevalence of overweight among US adults. The National Health and Nutrition Exa… (JAMA 1994) · cited 2391x in the literature
"Comparisons of the 1988 to 1991 overweight prevalence estimates with data from earlier surveys indicate dramatic increases in all race/sex groups. Overweight prevalence increased 8% between the 1976 to 1980 and 1988 to 1991 surveys. During this period, for adult men and women aged 20 through 74 years, mean body mass index increased from 25.3 to 26.3; mean body weight increased 3.6 kg." (abstract, results, passage verified)
pubmedfull study (doi)
GLP-1 receptor agonist medications improve HbA1c and lower LDL cholesterol through mechanisms independent of weight loss.
"they're seeing that LDL is lowering, A1C is lowering, like all these things are getting better that they don't even fully understand like why and how yet that are independent of weight loss." (said at 0:48:35)
Clinical trial data and pooled analyses demonstrate that glucagon-like peptide-1 (GLP-1) receptor agonists (and dual incretin agonists) improve glycemic control (HbA1c) and lipid parameters through direct incretin mechanisms that occur independently of weight change, although greater weight reduction confers additive improvements.
- supports: Association among weight change, glycemic control, and markers of cardiovascular risk with… (Cardiovascular diabetology 2015) · cited 73x in the literature
"Exenatide once weekly improved glycemic parameters independent of weight change, although the magnitude of improvement increased with increasing weight loss." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepat… (Journal of diabetes and its complications 2025) · cited 5x in the literature
"Short-term low-dose tirzepatide improves the lipid profile, HbA1c, and HSI in obese adults without DM, especially in those with abnormal baseline values. Lipid changes occurred independently of weight loss." (abstract, conclusions, passage verified)
pubmedfull study (doi)
NASA-sponsored bed rest studies at the University of Texas Medical Branch found that subjects placed on complete bed rest for 28 days at maintenance calories had no average muscle loss when supplemented with leucine-enriched essential amino acids.
"there were multiple studies sponsored through the University of Texas Medical Branch where they had people at complete bed rest for 28 days consuming a normal diet, so it was not a caloric deficit. Um they consumed a normal diet at maintenance calories, but no movement for 28 days, and they were given leucine-enriched essential amino acids multiple times a day. And there was a there uh the mean average of the group in general was no muscle loss." (said at 0:49:02)
In a randomized trial conducted at the University of Texas Medical Branch and supported by NASA, healthy subjects placed on strict bed rest for 28 days on a maintenance energy diet received leucine-enriched essential amino acid and carbohydrate supplementation three times daily between meals. The supplemented group experienced no average loss of lean leg mass (+0.2 ± 0.3 kg) compared to the unsupplemented control group (-0.4 ± 0.1 kg).
In whey protein powder, essential amino acids make up only approximately 45% of the total protein content.
"even in a whey protein powder, which is an awesome protein source, and steak is an awesome protein source, only about 45%, less than half of the protein is actually the essential amino acids" (said at 0:58:30)
Analytical profiles of dietary protein sources confirm that essential amino acids (EAAs) comprise approximately 43% to 50% of the total protein in whey protein, meaning less than half of the amino acid content consists of EAAs while the remainder consists of non-essential amino acids.
In 60-year-old women, consuming 3 grams of essential amino acids containing 40% leucine stimulates as much muscle protein synthesis as 20 grams of whey protein.
"in these studies, uh for example, just 3 g of essential amino acids, of which 40% was leucine... had the impact of 20 g of whey protein in women that were 60. Just 3 g. So not 3 g of leucine, 3 g of total essential amino acids so long as 40% of it was leucine." (said at 0:59:45)
A randomized controlled trial in older women (mean age 66 ± 2.5 years) directly compared a 3 g dose of leucine-enriched essential amino acids (containing 40% leucine, or 1.2 g leucine) to 20 g of bolus whey protein. The study evaluated muscle protein synthesis (MPS) via stable isotope tracer infusion at rest and following resistance exercise, finding that the 3 g leucine-enriched EAA formulation stimulated muscle protein synthesis equally to the 20 g of whey protein over 0–2 hours at rest and remained equivalently elevated over 0–4 hours when combined with exercise.
Taking essential amino acids prior to exercise increases the delivery of amino acids into muscle tissue due to increased exercise-induced blood flow.
"But on days when I'm training or during any type of like intense exercise, I also take it before I exercise because the increased blood flow moves more of the essential amino acids into the muscle. HOST: Ah. GUEST1: And there's a very important synergistic effect where you get that much more benefit from the exercise." (said at 1:10:10)
The claim is supported by clinical research evaluating the timing of essential amino acid (EAA) ingestion relative to exercise. Tipton et al. (2001) demonstrated that consuming essential amino acids and carbohydrates immediately prior to resistance exercise resulted in a significantly greater delivery of amino acids to muscle tissue during and after exercise compared to post-exercise ingestion, driven by increased exercise-induced hyperemia (blood flow), leading to a superior net muscle protein synthesis response.
Reductions in all-cause mortality, cancer, dementia, and heart disease are associated with raising the red blood cell omega-3 index from 4% to 8%.
"when you look at like kind of the reduction to all-cause mortality and reduction in specific cases of like cancer, dementia, heart disease, all these things, it's about getting your omega-3 levels in your red blood cells up from like 4% to 8%." (said at 1:20:13)
The Omega-3 Index measures the percentage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in red blood cell (RBC) membranes. A level below 4% is established in the literature as high risk, while a level of 8% or greater is established as the optimal cardioprotective target. Large prospective cohort analyses (including the Framingham Heart Study and the Fatty Acid and Outcome Research Consortium [FORCE]) demonstrate that higher RBC omega-3 status (e.g., highest vs. lowest quintiles, corresponding roughly to >6.8–8% vs. <4%) is inversely associated with all-cause mortality (approximately 17–34% lower risk) and cardiovascular disease events and mortality (approximately 21–39% lower risk), as well as reductions in cancer mortality and risk for neurodegenerative decline. Because these targets are derived primarily from prospective observational cohorts, these relationships represent robust epidemiologic associations rather than proven causal outcomes from randomized intervention trials.
- supports: Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality a… (Journal of clinical lipidology 2018) · cited 139x in the literature
"Those in the highest (>6.8%) compared to those in the lowest Omega-3 Index quintiles (<4.2%) had a 34% lower risk for death from any cause and 39% lower risk for incident CVD." (abstract, results)
pubmedfull study (doi) - supports: Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality. (Mayo Clinic proceedings 2024) · cited 21x in the literature
"After multivariable adjustment for relevant risk factors comparing the lowest to the highest quintiles of DHA, there was 17% lower risk of all-cause mortality (95% CI, 0.79 to 0.87; P<.0001), 21% lower risk for CV disease mortality (95% CI, 0.73 to 0.87; P<.001), 17% lower risk for cancer mortality (95% CI, 0.77 to 0.89; P<.0001), and 15% lower risk for all other mortality (95% CI, 0.79 to 0.91; P<.001)." (abstract, results)
pubmedfull study (doi) - supports: Omega-3 Index: an emerging biomarker in cardiovascular prevention. (Nutricion hospitalaria 2026)
"Levels below 4 % are associated with a very high risk of cardiovascular events and sudden death, whilst values above 8 % are considered indicative of high cardiovascular protection. Thanks to its ability to predict all-cause mortality and the incidence of cardiometabolic diseases, it has been considered a new biomarker of cardiovascular risk" (abstract, results, passage verified)
pubmedfull study (doi)
A daily intake of 3 grams of omega-3 fatty acids generally raises red blood cell omega-3 levels from 4% to 8%, and the standard pharmaceutical treatment dose is about 4 grams per day.
"But what I would say is generally if you're taking about 3 grams a day, you know, I think the um the pharmaceutical dose is like 4 grams a day when they're actually treating people. But 3 grams a day consistently, you are basically, you know, very likely to get to those higher levels." (said at 1:20:30)
The claim accurately describes both the effect of daily omega-3 supplementation on red blood cell omega-3 levels (the Omega-3 Index) and standard prescription omega-3 dosing. Research modeling dose-response across 14 clinical trials shows that supplementing with approximately 2 g to 3 g daily of EPA/DHA reliably increases red blood cell EPA+DHA levels from average baseline levels (~4.9%) up to targeted cardio-protective levels of around 8% or higher (PMID 31396625). Furthermore, scientific guidelines from the American Heart Association confirm that standard pharmaceutical prescription omega-3 treatments (such as Lovaza or Vascepa) are administered at a therapeutic dose of 4 g/day for clinical indications like severe hypertriglyceridemia (PMID 31422671).
Omega-3 fatty acids incorporate into cell membranes, making red blood cells more flexible.
"Omega-3s basically make your blood cells and everything much more flexible. And so when you can get it to be made up of more of that than these kind of stricter, harder fats, um it has, you know, these amazing benefits." (said at 1:20:55)
Omega-3 polyunsaturated fatty acids (such as EPA and DHA) readily incorporate into cell membrane phospholipids, displacing more rigid saturated fatty acids and increasing membrane fluidity. In animal and pathological models (such as sickle cell disease), DHA supplementation significantly reduces red blood cell (RBC) stiffness and enhances deformability. In human trials, omega-3 supplementation consistently increases membrane omega-3 content and improves the deformability of leukocytes, although in healthy subjects with baseline-flexible erythrocytes, detectable changes in RBC deformability can be subtle or vary depending on the measurement technique.
- supports: Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane f… (Blood cells, molecules & diseases 2015) · cited 34x in the literature
"In contrast, RBCs from SS mice fed DHA diet had markedly decreased stiffness and increased deformability compared to RBCs from SS mice fed CTRL diet. Furthermore, examination of peripheral blood smears revealed less irreversibly sickled RBCs in SS mice fed DHA diet as compared to CTRL diet. In summary, our findings indicate that DHA supplementation improves RBC flexibility" (abstract, results, passage verified)
pubmedfull study (doi) - context: Omega-3 supplementation changes the physical properties of leukocytes but not erythrocytes… (Prostaglandins, leukotrienes, and essential fatty acids 2024) · cited 5x in the literature
"Following supplementation, the mean±SD O3I increased from 5.3 %±1.5 % to 8.3 %±1.4 % (p < 0.001). No significant changes in RBC properties were found by both techniques. However, by DC we observed a consistent pattern of physical changes in lymphocytes, neutrophils and monocytes. Among these were significant increases in metrics correlated with the cells' deformability resulting in less stiff cells." (abstract, results)
pubmedfull study (doi) - supports: Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspecti… (Nutrients 2024) · cited 11x in the literature
"Recent studies have, however, highlighted interesting effects of EPA and DHA on erythrocyte membrane fluidity (EMF). EMF is governed by a complex and dynamic biochemical framework, with fatty acids playing a central role." (abstract, passage verified)
pubmedfull study (doi)
Fact-checked episodes
Publications
No PubMed publication profile has been built for this speaker yet.